Opus Genetics (IRD) Capital Expenditures (QoQ) (2010 - 2019)
Opus Genetics (IRD) Capital Expenditures (QoQ) (2010 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -52.95% |
| Sep 30, 2018 | 3,572.25% |
| Jun 30, 2018 | -61.39% |
| Mar 31, 2018 | -95.32% |
| Dec 31, 2017 | 1,455.33% |
| Sep 30, 2017 | -75.20% |
| Jun 30, 2017 | 251.70% |
| Mar 31, 2017 | 883.87% |
| Dec 31, 2016 | -46.41% |
| Sep 30, 2016 | -74.20% |
| Jun 30, 2016 | -36.58% |
| Mar 31, 2016 | -53.12% |
| Dec 31, 2015 | -75.56% |
| Sep 30, 2015 | 800.76% |
| Jun 30, 2015 | -43.88% |
| Mar 31, 2015 | -28.48% |
| Dec 31, 2014 | -30.40% |
| Sep 30, 2014 | 52.64% |
| Jun 30, 2014 | 176.93% |
| Mar 31, 2014 | 2.20% |